Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Michael B. Chancellor(18.8%)
Lipella Pharmaceuticals | D:發行公告
Lipella Pharmaceuticals | 10-Q:2024財年二季報
Lipella Pharmaceuticals | ARS:年度報告
Lipella Pharmaceuticals | DEF 14A:股東委託書決議
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 424B5:募資說明書
Lipella Pharmaceuticals | PRE 14A:並購重組委托聲明
Lipella Pharmaceuticals | 4:持股變動聲明-高管 Kaufman Jonathan H
Lipella Pharmaceuticals | 10-Q:2024財年一季報
Lipella Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Jonathan H. Kaufman(19.3%)
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 4:持股變動聲明-董事 Pruchnic Ryan
Lipella Pharmaceuticals | 4:持股變動聲明-董事 Yoshimura Naoki
Lipella Pharmaceuticals | 4:持股變動聲明-高管 Chancellor Michael B
Lipella Pharmaceuticals | 4:持股變動聲明-董事 Birder Lori
Lipella Pharmaceuticals | 4:持股變動聲明-高管 Kaufman Jonathan H
暫無數據